Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: MIST) Delayed: 0.92 --0 (-0%)
Previous Close $0.92    52 Week High
Open $0.93    52 Week Low
Day High $0.93    P/E N/A 
Day Low $0.90    EPS
Volume 673,985